Zosurabalpin (TFA)
Zosurabalpin TFA is a tethered macrocyclic peptide antibiotic, acting specifically on A. baumannii. Zosurabalpin TFA inhibits lipopolysaccharide-transport[1].
Product Specifications
Product Name Alternative
Abx MCP (TFA) ; RG6006 (TFA)
UNSPSC
12352005
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/zosurabalpin-tfa.html
Solubility
10 mM in DMSO
Smiles
O=C1NCC2=C(C3=CC=C(C=C3)C(O)=O)C=CC=C2SC4=NC=CC=C4CN[C@H](C(N[C@H](C(N([C@H]1CC5=CNC6=CC=CC=C56)C)=O)CCCCN)=O)CCCN.OC(C(F)(F)F)=O.[x]
Molecular Formula
C43H50N8O5S.xC2HF3O2
Molecular Weight
790.97 (free base)
References & Citations
[1]Karanbir S Pahil, et al. A new antibiotic traps lipopolysaccharide in its intermembrane transporter. Nature. 2024 Jan;625 (7995) :572-577.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
